Literature DB >> 26367089

Sjögren syndrome: what and where are we looking for?

Cintia S de Paiva1, Eduardo Melani Rocha.   

Abstract

PURPOSE OF REVIEW: Sjögren's syndrome affects exocrine glands leading to a dry mouth and dry eyes. Dry eye manifestations can precede the diagnosis of Sjögren's syndrome by many years. Innumerous spontaneous and inducible Sjögren's syndrome models have been used to study the pathogenesis of Sjögren's syndrome. This review focuses on recent human data, ocular and extraglandular manifestations of animal models, what is known, what is still unknown and how we need to look, and their correlation correspondence to human disease. RECENT
FINDINGS: Hallmarks of dry eye in Sjögren's syndrome include increased corneal staining, goblet cell loss and low tear volume. Confocal microscopy and impression cytology are able to clarify new markers of the ocular disease. Extraglandular manifestations should be an alert more severe complications in the eye. Some models have strong sex and exocrine gland predilection, whereas aging generally worsens the disease phenotype. Although most models do not display a significant increase in corneal staining or tear secretion impairment, conjunctival infiltration and decrease in goblet cells are frequently seen.
SUMMARY: We have seen great advances in the role of inflammation in ocular, oral and extra-glandular manifestations of Sjögren's syndrome. Several mechanisms and mediators of Sjögren's syndrome have been elucidated in animal model studies.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26367089      PMCID: PMC4631031          DOI: 10.1097/ICU.0000000000000208

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  83 in total

1.  The second definition of Sjögren's syndrome as an autoimmune disorder.

Authors:  Juan Murube
Journal:  Ocul Surf       Date:  2010-10       Impact factor: 5.033

2.  Eye changes in autoimmune NZB and NZB x NZW mice. Comparison with Sjögren's syndrome.

Authors:  H S Kessler; M Cubberly; W Manski
Journal:  Arch Ophthalmol       Date:  1971-02

3.  Characterization of T cell receptor repertoire and anti-Ro/SSA autoantibodies in relation to sialadenitis of NOD mice.

Authors:  K Skarstein; M Wahren; E Zaura; M Hattori; R Jonsson
Journal:  Autoimmunity       Date:  1995       Impact factor: 2.815

4.  Effect of human vasoactive intestinal peptide gene transfer in a murine model of Sjogren's syndrome.

Authors:  B M Lodde; F Mineshiba; J Wang; A P Cotrim; S Afione; P P Tak; B J Baum
Journal:  Ann Rheum Dis       Date:  2005-06-23       Impact factor: 19.103

5.  A dual role for interferon-gamma in the pathogenesis of Sjogren's syndrome-like autoimmune exocrinopathy in the nonobese diabetic mouse.

Authors:  S Cha; J Brayer; J Gao; V Brown; S Killedar; U Yasunari; A B Peck
Journal:  Scand J Immunol       Date:  2004-12       Impact factor: 3.487

6.  Age-related T-cell cytokine profile parallels corneal disease severity in Sjogren's syndrome-like keratoconjunctivitis sicca in CD25KO mice.

Authors:  Cintia S De Paiva; Cindy S Hwang; John D Pitcher; Solherny B Pangelinan; Ehsan Rahimy; Wei Chen; Kyung-Chul Yoon; William J Farley; Jerry Y Niederkorn; Michael E Stern; De-Quan Li; Stephen C Pflugfelder
Journal:  Rheumatology (Oxford)       Date:  2009-12-09       Impact factor: 7.580

7.  The effect of neonatal sex hormone manipulation on the incidence of diabetes in nonobese diabetic mice.

Authors:  T Hawkins; R R Gala; J C Dunbar
Journal:  Proc Soc Exp Biol Med       Date:  1993-02

8.  Dry eye-induced conjunctival epithelial squamous metaplasia is modulated by interferon-gamma.

Authors:  Cintia S De Paiva; Arturo L Villarreal; Rosa M Corrales; Hassan T Rahman; Victor Y Chang; William J Farley; Michael E Stern; Jerry Y Niederkorn; De-Quan Li; Stephen C Pflugfelder
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-06       Impact factor: 4.799

9.  Pathogenic effect of interleukin-17A in induction of Sjögren's syndrome-like disease using adenovirus-mediated gene transfer.

Authors:  Cuong Q Nguyen; Hongen Yin; Byung Ha Lee; Wendy C Carcamo; John A Chiorini; Ammon B Peck
Journal:  Arthritis Res Ther       Date:  2010-12-23       Impact factor: 5.156

10.  Altered balance of interleukin-13/interferon-gamma contributes to lacrimal gland destruction and secretory dysfunction in CD25 knockout model of Sjögren's syndrome.

Authors:  Fang Bian; Flavia L Barbosa; Rosa M Corrales; Flavia S A Pelegrino; Eugene A Volpe; Stephen C Pflugfelder; Cintia S de Paiva
Journal:  Arthritis Res Ther       Date:  2015-03-10       Impact factor: 5.156

View more
  4 in total

Review 1.  Immune - Goblet cell interaction in the conjunctiva.

Authors:  Jehan Alam; Cintia S de Paiva; Stephen C Pflugfelder
Journal:  Ocul Surf       Date:  2020-01-14       Impact factor: 5.033

2.  Pathological Analysis of Ocular Lesions in a Murine Model of Sjögren's Syndrome.

Authors:  Aya Ushio; Rieko Arakaki; Hiroshi Eguchi; Fumika Hotta; Akiko Yamada; Yasusei Kudo; Naozumi Ishimaru
Journal:  Int J Mol Sci       Date:  2017-06-06       Impact factor: 5.923

3.  The Effectiveness and Safety of Total Glucosides of Paeony in Primary Sjögren's Syndrome: A Systematic Review and Meta-Analysis.

Authors:  Zhe Feng; Bi-Qing Zhang; Ya-Mei Zhu; Bei-Bei Yu; Ling Fu; Ling-Ling Zhou; Xue-Ping Zhou; Yan Lu
Journal:  Front Pharmacol       Date:  2019-05-24       Impact factor: 5.810

Review 4.  Oxidative Stress in the Protection and Injury of the Lacrimal Gland and the Ocular Surface: are There Perspectives for Therapeutics?

Authors:  Camila Nunes Lemos; Lilian Eslaine Costa Mendes da Silva; Jacqueline Ferreira Faustino; Marina Zilio Fantucci; Adriana de Andrade Batista Murashima; Leidiane Adriano; Monica Alves; Eduardo Melani Rocha
Journal:  Front Cell Dev Biol       Date:  2022-03-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.